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DIAGNOSTIC ABILITY OF CYCLIN D1 AND PRO 
APOPTOTIC MARKERS CASPASE 3 AND P21 FOR 
DETECTION OF REGIONAL METASTASES IN 
LARYNGEAL CANCER PATIENTS
Alexandr Kovtunenko,
MD, Professor, SE “Dnipropetrosk medical academy of Heals Ministry of Ukraine”
Serhij Tymchuk, MD,
Bohdan Shportko, 
Dnipropetrovsk regional hospital named after I.I. Mechnikov
Annotation. Laryngeal squamous cell carcinoma has a high ability to metastasis into regional 
lymph nodes. The study of molecular markers of cyclin D1 showed its expression at the level of 
58.3 (18.5)% (M (SD)) for the group of laryngeal squamous cell carcinoma without metastases 
- 48.6 (17.7)%, for the group with metastases - 66.0 (15.3)% (P <.001), the investigated level 
of expression  of p21WAF ranged from 18% to 94% and on average amounted to 55.3 (22.1)%, 
for the group without metastases - 45.2 (26.0)%, for the group with metastases - 63.3 (14.3)% (P 
<.001). High expression of caspase 3 was detected in 40 (57.1)% and it was significantly lower 
(P <.001) in the group without metastases 10 (32.3)% as compared with the group of laryngeal 
cancer patients with regional metastases - 30 (76.9)%. In statistical analysis of the data obtained 
it was established that cyclin D1has the highest value of AUC (0.780), caspase-3 -  somewhat 
lower (0.719) and  p21WAF has the lowest one (0.694) (P <.01). Investigation of these markers 
can be used for determining the prognosis of the disease course and the choice of extent of lymph 
dissection. No reliable association was revealed between the expression of these markers with 
recurrent laryngeal squamous cell carcinoma and the degree of tumor differentiation. Additional 
studies of these markers can deepen our knowledge on molecular biology of the tumor and 
prognosis of the disease course.
Keywords: Laryngeal squamous cell carcinoma, metastases, molecular markers, cyclin D1, 
caspase 3, p21WAF.
Introduction. Laryngeal cancer is a frequent localization of squamous cell 
carcinoma of the head and neck [1, 2]. In spite of advances in surgical, radiation and 
other curative methods of treatment of squamous cell carcinoma of the head and neck, 
the survival of patients with this disease remains unchanged. The main factor influencing 
the survival of patients is the presence of regional metastases.
Such fundamental principles of prognosis of tumorous course, specifically 
metastasis, as TNM classification or the degree of tumor differentiation are being used 
for a long time. There are two opposite approaches to the management of patients with 
laryngeal cancer with N0 - the strategy of «wait and watch» and preventive intervention 
on the lymphatic system of the neck [3-5].
Considering new knowledge, the study of molecular features of the tumor makes 
it possible to predict aggressive tumor growth and probability of tumor metastasis. 
Determination of tumor aggression and prognosis of metastasis can be used to decide 
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the disputable issue of the extent of surgical intervention on the lymphatic system of the 
neck [6]. 
Cyclin D1 is a protein responsible for the G1 and S phase of the mitotic cycle 
in normal and tumor cells, in its expression in tumor cells one can expect shortening 
of G1 phase and very high proliferative activity[2,7]. Some scientific studies suggest 
that overexpression of cyclin D1 in squamous cell carcinomas of the head and neck is 
associated with poor prognosis for patients, continued growth, locoregional recurrences 
and metastasis [1,2,7]. 
Some studies point at the relationship of tumor aggression and its resistance to 
treatment with disorder of apoptosis of cancer cells. Disorder of apoptosis processes 
leads to uncontrolled and aggressive growth of the tumor. Caspase 3 is closely related to 
such essential components of apoptosis as TNF-a[8]. The relationship of caspase-3 with 
a poor prognosis of malignant tumors for other localizations has been proven [9]. 
Research of Chiappara G. et al. (2014) on effector caspase-3 as a distributor of 
apoptosis and cytoplasmic expression of inhibitor of cyclin-dependent kinase p21WAF1, 
involved in the arrest of growth of cellular cycle through such stress factors as cigarette 
smoke in samples of airways epithelium of smokers, showed interesting results. In the 
epithelium of smokers there is determined increased expression of p21 and of activated 
caspase-3, which correlate with each other, and thus they play the role of pro-apoptotic. 
Besides, change in the expression of p21 may be associated with inhibition of tissue 
repair in smokers, as evidenced by the low level of expression of such proliferation 
markers as Ki-67 and PCNA [7].
Materials and methods. The study was approved by the ethics committee of the 
SE «DMA» and ME «RCHM.» Histological material for research was taken from the 
archives of ME “Regional pathologicoanatomic office». All patients gave consent to 
the processing of personal data and participation in the study. To perform tasks of the 
research under the supervision there were 70 patients with laryngeal cancer III - IV stages 
(T3-4N0-3M0) and II clinical group who underwent examination, treatment and follow-
up in ENT- oncology department of Dnipropetrovsk Regional Clinical Hospital named 
after I.I. Mechnikov over the period from 2011 to 2014. Of them, 39 patients of the main 
group had regional metastases of laryngeal cancer, in 31 patients of comparison group 
regional metastases were not revealed. The age of patients ranged from 33 to 74 years. 
Male patients were in the absolute majority - 99% No=69. In all patients squamous cell 
carcinoma was diagnosed histologically. The demographic characteristics of patients is 
presented in the Table 1.
All patients underwent surgical treatment – laryngectomy and variants of 
lymphodissection. Histological examination and evaluation of expression of 
immunohistochemical markers of laryngeal squamous cell carcinoma (LSCC) was 
performed by two independent pathologists according to WHO recommendations on 
histological classification of laryngeal tumors [10].
Immunohistochemical study. Histological sections of 4-6 mkm thickness were 
applied on adhesive subject glasses SuperFrost Plus, after dewaxing and rehydration, 
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temperature retrieval of antigens was performed - sections were placed in citrate buffer 
with pH 6.0 and heated in the  autoclave at a temperature +121°C during 8 minutes, 
activity of endogenous peroxidase was inhibited by 3% hydrogen peroxide solution 
during 20 minutes. Further, incubation of sections with primary antibodies was performed 
in humid chambers at a temperature of 23-25C during 30 minutes.
Monoclonal antibodies to cyclin D1, (Clone SP4, TermoScientific, USA) in dilution 
1:100, caspase-3 (Clone 31A893, TermoScientific, USA) in dilution 1:50 and p21 WAF1 
(Clone SR74, TermoScientific, USA) were used as primary ones. Specimens were stained 
with Meyer hematoxylin and fixed.
Evaluating IHC reactions with marker cyclin D1, the level of intranuclear expression 
was calculated as the percentage of cells with nuclear reaction to 1000 keratinocytes in 
image enlargement (× 400) by 4 gradations: (0) less than 2% of stained cells, (1+) – from 
2% to 25%, (2 +) - from 26% to 50%, (3+) - from 51% to 75%, (4+) - 76% to 100%. 
Gradations (0 - 2+) (<50%) were regarded as a low expression and (3+ - 4+) (> 50%) as 
high, by recommendations of Gülçin Şimsek et al [11] Fig. 1.
Investigating effector caspase 3 by means of monoclonal antibody Caspase 3, 
intensity score was determined by the following gradation: from 0 - no reaction, 1- weak 
reaction (a little number of stained cells or pale color staining), 2 - the greatest median 
staining, 3 - strong staining of almost all cells, by recommendations [12,13]. Fig.1.
In the samples of LSCC marker p21 demonstrated exclusively intranuclear 
expression, which was calculated as a percentage of stained brown nuclei per 100 of 
tumor cells. For statistical analysis the obtained data of expression were divided into two 
groups: high expression (> 20%) and low (≤20%)[14,15]. Fig.1.
Statistical data processing. Validation for compliance of distribution of quantitative 
characteristics to normal law was performed by Shapiro-Wilk criterion (The Shapiro-
Wilk test). In terms of normal distribution for comparison of continuous data in different 
groups, double-sided t-test (t test) was used. For comparison of continuous data which 
were not distributed normally, two-tailed Mann-Whitney’s test (Mann-Whitney U test) 
was used. Probability of differences of categorical data was evaluated by criterion 
Pearson’s Xi-square  (χ2) (Pearson Chi-square), including Yates’ continuity-corrected 
(Yates Chi-square) for the values  close to 0 or 100%.
To assess discriminatory power of different immunohistochemical markers for 
prediction of regional metastasis of laryngeal cancer (diagnostic value of the test) ROC-
analysis was used. (ROC Analysis, ROC - Receiver Operating Characteristic). The 
result was represented as the value  of the area under the ROC-curve (AUC - Area Under 
Curve), built on indicator values of sensitivity (Se) and specificity test (SP) and with 
involving  of 95% confidence interval (95% CI). ROC-analysis was considered adequate 
in probably significant (PS) difference of AUC value from 0.5 value. Calculations of 
standard error of the area under the curve (AUC) and difference between the two AUCs 
were carried out by the method of DeLong et al. (1988) [16].
By the shape of the ROC curve and the area under it (AUC) comparisons of 
predictive powers of diagnostic markers were made. The closer is the curve to the upper 
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left-hand corner, and accordingly, the larger the area under the curve, the better is the 
discriminatory power of the test. Values of the area under the ROC curve were interpreted 
in terms of diagnostic accuracy by Šimundić A-M. (2009): 0.9-1.0 - excellent, 0.8-0.9 
- very good, 0.7-0,8 – good, 0.6-0.7 - average, 0.5-0.6 - poor; value of 0.5 points at 
invalidity of the method[17].
Statistical processing of the data was performed using the statistical software R 
(https://cran.r-project.org) and MedCalc Version 17.2 free trial version (https://www.
medcalc.org/download.php).
Research results. Expression index of cyclin D1 ranged from 18% to 94% and on 
average amounted to 58.3 (18.5)% (M (SD)), for the group of LSCC without metastases 
it was 48.6 (17.7)%, for the group with metastases - 66.0 (15.3)% (P <.001). Level 
of P21WAF expression ranged from 18% to 94% and on average amounted to 55.3 
(22.1)%, for the group without metastases - 45.2 (26.0)%, for the group with metastases 
- 63.3 (14.3)% (P <.001) - Table 1.
The frequency of high expression of caspase-3 in the total sample was 40 (57.1)% 
and it was significantly lower (P <.001) in the group without metastases 10 (32.3)% 
as compared to the group of laryngeal cancer patients with regional metastases - 30 
(76.9)%.
In comparison with the group without metastasis, in the group with regional 
metastases the level of expression of cyclin D1 is significantly (P <.001) less by -17.4% 
(95% CI -25.3 - -9.5), that of p21WAF - by -18.1 (95% CI -27.8 - - 8.3)%  (P <.001).
The frequency of high expression of caspase-3 for all investigated was reliably (P 
<.001) higher by 44,6 (95% CI 19.5 - 64.2) in the group with regional metastases as 
compared with the group without metastases.
In subgroups on the degree of tumor differentiation, significant discrepancies are 
observed in cyclin D1 and caspase-3 for subgroup of moderate differentiation only, while 
for p21WAF - in all subgroups, except for the low differentiation of the tumor. Absence 
of reliability of differences in subgroups according to the degree of tumor differentiation 
is explained by the small amount of observations in each subgroup separately.
The evaluation of results of diagnostic accuracy of cyclin D1, p21WAF and caspase-3 
for predicting metastasis of laryngeal cancer are shown in the Table 2 and Figure 2.
It should be noted that for all markers there is observed dependence in the increase 
of predictive value of the test at a higher degree of tumor differentiation. So, for p21WAF 
in a higher degree of differentiation of the tumor, the area under the ROC-curve reaches 
almost the maximum value (0.927), while for the moderate one it makes up AUR = 
0.676. Prognostic value of most markers in subgroups, defined by the degree of tumor 
differentiation is not statistically reliable (P> .05 for AUR).
By means of ROC-analysis the comparison of predictive power of 
immunohistochemical markers as for regional metastases of laryngeal cancer was made.
Comparison of all ROC curves against each other showed no significant divergences 
between them. p21WAF has the greatest sensitivity- 97.4% (95% CI 86.5 - 99.9%), 
cyclin D1 has less - 87.2% (72.6 - 95.7%) and caspase 3 has the least - 76.9% (60.7 - 
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88.9%). Levels of specificity are somewhat lower and make up 45.2 % (27.3 - 64.0%); 
61.3% (42.2 - 78.2%) and 67.74% (48.6 - 83.3%) respectively.
The areas under the ROC-curve of all studied immunohistochemical markers are 
more than 0.5 (P <.01), thus having predictive value regarding the prediction of laryngeal 
cancer metastasis. The higher the AUC, the greater is prognostic (diagnostic) value of 
the test. The greatest value of AUC (0.780) was established for cyclin D1 (Table. 2, Fig. 
2), it is somewhat less for caspase-3 (0.719) and the lowest AUC (0.694) is for p21WAF. 
So, diagnostic accuracy regarding prognosis of metastatic laryngeal cancer may be 
described as good for cyclin D1 and caspase-3 and as medium - for p21WAF. Pairwise 
comparison of operating characteristics of immunohistochemical markers against each 
other was performed by the method of DeLong et al. (1988). The difference between the 
areas under ROC-curves of caspase-3 and p21WAF was 0.025 (95% CI -0,109 - 0.158); 
between caspase-3 and cyclin D1 - 0.060 (95% CI -0,041 - 0.162); between p21WAF 
and cyclin D1 - 0.085 (95% CI -0,040 - 0.210). Significance level of the difference 
between the areas under the ROC-curves markers is greater than   critical level - 5% (P> 
.05 for all comparison pairs), prompting suggestions that two comparable areas are not 
significantly different, so significant differences in prognostic tests were not found.
So, cyclin D1, p21WAF and caspase-3 can be used for prediction of regional 
metastatic laryngeal cancer, but cyclin D1 has the best operating characteristics according 
to ROC analysis, diagnostic accuracy of the latter can be described as good.
 To assess possibilities of predicting recurrence of laryngeal tumors on the basis 
of defining cyclin D1, p21WAF and caspase-3, ROC analysis was made as well (Fig. 
3). In cyclin D1 and p21WAF statistical significance of AUR is not reliable (P> .05). 
Statistically significant results were obtained only for caspase-3: sensitivity - 84.6%, 
specificity - 49.1%; area under the ROC-curve - 0.668 (P = .018), by classification of 
diagnostic accuracy it can be interpreted as medium. 
In all studied markers there was observed low specificity and predictive value of 
positive results. Predictive value of negative result and sensitivity is sufficiently high, 
this indicate that markers do not miss patients with possible relapses, as almost do not 
give false negative results.
Discussion. TNM classification remains one of the most convenient and reliable 
method for determining probability of laryneal cancer metastasis. However, it does not 
include molecular properties of the tumor at the stages of carcinogenesis. Recently, 
studies on  disorder of the cellular cycle, particularly of expression of marker  Cyclin 
D1 are being conducted. For example in his study Pignataro L. (2005) proved that 
increased expression of Cyclin D1 was observed more in stage T3-4 than in stage T1-
2, he also studied the relationship of this molecular marker with metastatic laryngeal 
cancer. Futhermore, the reverse correlation with p27has been proven; this significantly 
worsened prognosis for the patients.18 At this time Morshed K. et al. (2007) considers 
cyclin D1 as an independent prognostic factor.19 This divergence of results demands 
explanation.
Our data on statistically significant increase in expression of cyclin D1 in the 
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presence of metastases in regional lymph nodes of the neck are confirmed by the studies 
of other authors. So, Pignataro L. (2005) who revealed correlation of cyclin D1 with 
regional metastases at the same time does not find association of expression of marker 
with the degree of tumor differentiation[16].
Inactivation of programmed cell death pplays a very important role in the 
functioning of multicellular organisms. Cellular death is regulated by family of caspases, 
in particularly caspase 3 (cysteine  protease) [20-22].  Role of caspase 3 was studied in 
the samples of LSCC by means of homonymous molecular marker and increase in the 
level of its expression with presence of metastases was proven.
P21 WAF1 is a protein, its expression was also analyzed in our work together with 
caspase-3 in the group of pro-apoptotic markers. This marker is responsible for arrest 
of the  cellular cycle in the phase G1 in response to hypersecretion of protein p53 and 
DNA lesion. Increased activity of p53, in turn, may enhance signal of apoptosis through 
the impact on expression of genes Bax and Bc1-2, if they do not mutate and continue 
to perform their function. Impact of a wide range of factors for p21 WAF1 makes it 
interesting for investigation of LSCC.
Thus, the study of the cellular cycle, especially investigation of oncosupressor p53 is 
the gold standard for LSCC prediction together with proliferative activity of the  marker 
Ki-67, while others need further study.
The study of molecular markers of cyclin D1 showed its expression at the level of 
58.3 (18.5)% (M (SD)), for the group of LSCC without metastases - 48.6 (17.7)%, for 
the group with metastases - 66.0 (15.3)% (P <.001), the investigated level of expression 
of p21 WAF1 ranged from 18% to 94% and on average made up 55.3 (22.1)%, for 
the group without metastases - 45.2 (26.0)%, for the group with metastases - 63.3 
(14.3)% (P <.001). High expression of caspase 3 was revealed in 40 (57.1)% and was 
significantly lower (P <.001) in the group without metastases - 10 (32.3)% as compared 
with the group of laryngeal cancer patients with regional metastases - 30 (76.9)%. In the 
statistical analysis of data the largest value of AUC (0.780) was established for cyclin 
D1,  somewhat lower (0.719) – for caspase-3 and the lowest value of AUC (0.694) - 
for p21 WAF1 (P <.01). Cyclin D1 has a good diagnostic value and can be used as an 
additional method for prediction of regional metastases of laryngeal cancer. However, 
the practical use of this marker as a prognostic one towards  choosing the extent of 
surgical intervention on lymph structures of the neck requires further study. Separately, it 
should be noted that this study revealed no interrelationship between cyclin D1, caspase 
3 and p21 WAF1and  the degree of differentiation of laryngeal cancer and its recurrences, 
but more in-depth study of molecular markers in the future may reveal other patterns of 
tumor growth and be used in practice for prediction and personalization of treatment.
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Table 1
 
Characteristics
 Total 
Sample 
(No. 70)
Main group with 
regional metastases 
(No. 39)
Group of comparison 
without regional metastases 
(No. 31)
P value
Demographics characteristics
Males, No. (%) 69 (98.6) 38 (97.4) 31 (100.0) .369
Mean age М (SD) Age, Mean (SD) 61.9 (9.5) 61.0 (8.5) 63.0 (10.7) .385
 Clinical Values
Degree of tumor differentiation, No. (%)
Hogh G1 14 (20.0) 6 (15.4) 8 (25.8)
.523Moderate G2 45 (64.3) 26 (66.7) 19 (61.3)
Low G3 11 (15.7) 7 (17.9) 4 (12.9)
Tumor recurrences, No. (%) 13 (18.6) 11 (28.2) 2 (6.5) .020
Cyclin D1 %, Mean (SD)
Degree of tumor differentiation 
Hogh G1 46.5 (14.9) 54.2 (15.7) 40.8 (12.3) .098
Moderate G2 59.4 (18.4) 68.3 (14.0) 47.3 (16.9) <.001
Low G3 68.5 (16.3) 67.6 (17.5) 70.3 (16.5) .808
Total Cyclin D1 58.3 (18.5) 66.0 (15.3) 48.6 (17.7) <.001
p21 WAF %, Mean (SD)
Degree of tumor differentiation 
Hogh G1 35.0 (22.8) 53.3 (14.2) 21.3 (17.9) .004
Moderate G2 58.1 (19.8) 63.8 (13.7) 50.3 (24.3) .022
Low G3 69.7 (11.4) 70.1 (13.9) 69.0 (6.8) .174
Total p21 WAF 55.3 (22.1) 63.3 (14.3) 45.2 (26.0) <.001
Caspase-3, rate of high expression, No. (%)
Degree of tumor differentiation 
Hogh G1 7 (50.0) 5 (83.3) 2 (25.0) .106
Moderate G2 23 (51.1) 18 (69.2) 5 (26.3) .011
Low G3 10 (90.9) 7 (100.0) 3 (75.0) .770
Total caspase-3 40 (57.1) 30 (76.90) 10 (32.3) <.001
Demographic and clinical characteristics of laryngeal cancer patients included in 
the study
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Table 2
Prognosis 
of metastases
% (95 % СІ) P 
value
Optimal 
cut-off 
pointSe Sр PPV NPV AUC
Cycline D1 87.2 (72.6 to 95.7)
61.3  (42.2 to 
78.2)
73.9  (56.6 to 
90.3)
79.2  (59.7 
to89.6)
0.780 (0.665 to 
0.870) <.001 48 %
Degree of tumor differentiation 
High G1 66.7(22.3 to 95.7)
87.5
(47.3 to 99.7)
80.0
(33.9 to97.8)
77.8
(33.4 to 99.4)
0.729 (0.434 to 
0.924) .165 48 %
Moderate G2 84.6(65.1 to 95.6)
73.7
(48.8 to 90.9)
81.5
(60.0 to 94.6)
77.8 
(54.3 to 92.5)
0.843
(0.704 to 0.934) <.001 58 %
Low G3 25.0(0.6 to 80.6)
100.0
(59.0 to 100.0)
66.7 
(12.7 to 93.2)
40.0
(10.1 to 90.2)
0.571
(0.254 to 0.850) .725 74 %
p21 WAF 97.4(86.5 to 99.9)
45.2
(27.3 to 64.0)
69.1
(50.5 to 98.9)
93.3
(70.3 to 96.8)
0.694
(0.573 to 0.799) .004 40 %
Degree of tumor differentiation 
Hogh G1 100.0(54.1 to 100.0)
87.5
(47.3 to 99.7)
85.7
(43.5 to  NaN)
100.0
(57.9 to 
100.0)
0.927
(0.659 to 0.998) <.001 34 %
Moderate G2 96.2(80.4 to 99.9)
42.1
(20.3 to 66.5)
69.4
(44.2 to 98.9)
88.9
(56.7 to 95.6)
0.676
(0.520 to 0.808) .048 46 %
Low G3 71.4(29.0 to 96.3)
0
(0.0 to 60.2)
100.0
(24.8 to 100.0
44.4
(7.1 to NaN)
0.518
(0.213 to 0.813) .928 82 %
Caspase-3 76.9(60.7 to 88.9)
67.7
(48.6 to 83.3)
75.0
(57.5 to 87.8)
70.0
(51.9 to 84.7)
0.719
(0.599 to 0.820) <.001 2++
Degree of tumor differentiation 
Hogh G1 83.3(35.9 to 99.6)
75.0
(34.9 to 96.8)
71.4
(30.9 to 99.2)
85.7
(40.2 to 98.4)
0.792
(0.498 to 0.956) .013 2++
Moderate G2 69.2(48.2 to 85.7)
73.7
(48.8 to 90.9)
78.3
(55.1 to 90.5)
63.6
(42.0 to 86.1)
0.727
(0.573 to 0.849) .001 2++
Low G3 0(0.0 to 41.0)
100.0
(39.8 to 100.0)
70.0
(4.3 to NaN)
100.0
(17.1 to 
100.00
0.518
(0.213 to 0.813) .935 2++
Se – Sensitivity
Sр – Specificity
PPV – Positive predictive value. 
NPV – Negative predictive value.
AUC – Area Under Curve.
Optimal cut-off point 
Evaluation of possibilities of predicting regional metastases of laryngeal cancer 
based on defining cyclin D1,  p21 WAF  and caspase-3 (operating characteristics by the 
data of ROC analysis)
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Figure 1. 
Immunohistochemical investigation of laryngeal squamous cell carcinoma
Microscopic investigation of laryngeal squamous cell carcinoma showed high expression of immuno-
histochemical markers: cyclin D1 expression ≤50% (A), expression >50% (B); caspase-3 low level 
of expression (C), high level of expression (D) and p21WAF1 level of expression ≤20% (E), level of 
expression  >20% (F) (image enlargement ×40).
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Figure 2
ROC curves for predicting regional metastases of laryngeal cancer based on defining cyclin D1,  
p21WAF  and caspase-3
Figure 3
ROC curves of predicting recurrence of laryngeal tumor based on defining cyclin D1,  p21WAF  and 
caspase-3
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